Page last updated: 2024-08-23

etoposide and Demyelinative Myelitis

etoposide has been researched along with Demyelinative Myelitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alvarnas, JC; Blume, KG; Chao, NJ; Horning, SJ; Hu, WW; Long, GD; Negrin, RS; Schriber, JR; Stockerl-Goldstein, K; Tierney, K; Wong, R1

Other Studies

1 other study(ies) available for etoposide and Demyelinative Myelitis

ArticleYear
High-dose therapy with hematopoietic cell transplantation for patients with central nervous system involvement by non-Hodgkin's lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2000, Volume: 6, Issue:3A

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Cognition Disorders; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disease Progression; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelitis, Transverse; Neoplasm Invasiveness; Quality of Life; Radiation Injuries; Survival Analysis; Survival Rate; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation

2000